Published on September 1, 2017
WEDNESDAY, August 30, 2017 (TIME) — The Food and Drug Administration (FDA) followed the advice of its advisory committee and approved a breakthrough treatment for children with acute lymphoblastic leukemia (ALL) on Wednesday. It’s the first gene therapy approved in the U.S.
Dr. Carl June, director of the center for cellular immunotherapies at University of Pennsylvania’s Abramson Cancer Center, who pioneered the therapy, was still emotional an hour after receiving the news of the approval in an email.
You might have also missed…
Drug Aimed at Inflammation May Lower Risk of Heart Disease and Cancer
Aug. 27, The New York Times
How your selfies could help detect pancreatic cancer
Aug. 30, USA Today
Ovarian cancer symptoms and warning signs
Aug. 31, Fox News